Accumulating evidence that low RASSF6 expression predicates poor prognosis in multiple gastrointestinal tumors, such as gastric cancer, hepatocellular carcinoma, pancreatic ductal adenocarcinoma. The gene discussed is RASSF6; the disease is gastric cancer.